Sandra Mazzoni, DO, discussed a study presented at the ASCO Annual Meeting that used artificial intelligence to analyze patterns in how patients with multiple myeloma respond to therapy. The study utilized a database of hundreds of patients with myeloma to identify genetic patterns that correlate with different outcomes in overall survival. Mazzoni, a hematologist at the Cleveland Clinic, explained that this study demonstrates the potential of artificial intelligence in personalized medicine. This research was presented at the ASCO Annual Meeting in Chicago.
Source link
AI learning may reveal treatment outcome patterns in multiple myeloma
